C12N 9/2451
Acting on alpha-1,6-glucosidic bonds
Official title: {acting on alpha-1,6-glucosidic bonds}
C12N9/2451 (Acting on alpha-1,6-glucosidic bonds) appears on 217 US grants and 202 published applications in this corpus.
Search patents in C12N- Granted patents
- 217
- Published applications
- 202
- Assignees
- 144
- Inventors
- 576
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 3 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 4 | 0 |
| 1985 | 0 | 0 |
| 1986 | 4 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 5 | 0 |
| 1995 | 5 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 9 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 7 | 1 |
| 2002 | 13 | 7 |
| 2003 | 6 | 13 |
| 2004 | 3 | 8 |
| 2005 | 7 | 2 |
| 2006 | 2 | 6 |
| 2007 | 4 | 0 |
| 2008 | 5 | 5 |
| 2009 | 3 | 9 |
| 2010 | 5 | 1 |
| 2011 | 5 | 7 |
| 2012 | 1 | 7 |
| 2013 | 5 | 10 |
| 2014 | 9 | 5 |
| 2015 | 1 | 6 |
| 2016 | 7 | 12 |
| 2017 | 3 | 10 |
| 2018 | 5 | 10 |
| 2019 | 5 | 12 |
| 2020 | 12 | 11 |
| 2021 | 7 | 8 |
| 2022 | 6 | 12 |
| 2023 | 5 | 11 |
| 2024 | 5 | 8 |
| 2025 | 9 | 12 |
| 2026 | 6 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Therapeutics for glycogen storage disease type iii11 Aug 2026US 12,703,858 B2Ultragenyx Pharmaceutical Inc.
- Compositions for producing fermentation products16 Jun 2026US 12,655,402 B2Novozymes A/S
- Sugar composition containing cyclic tetrasaccharide, use thereof, and production method therefor2 Jun 2026US 12,644,142 B2Nagase Viita Co., Ltd.
- Mini-GDE for the treatment of glycogen storage disease III26 May 2026US 12,637,668 B2Association Institut De Myologie
- Processes for producing fermentation products26 May 2026US 12,637,699 B2Novozymes A/S
- Mutant of type iii pullulan hydrolase with enhanced enzymatic activity and construction method thereof17 Sep 2026US 2026/0275316 A1Institute of Microbiology, Jiangxi Academy of Sciences (Jiangxi Institute of Watershed Ecology)
- Mini-gde for the treatment of glycogen storage disease iii10 Sep 2026US 2026/0265720 A1Association Institut De Myologie
- N-terminal truncated gde for the treatment of glycogen storage disease iii20 Aug 2026US 2026/0242762 A1Genethon
- Enzyme composition for treating dental plaque and plaque bacterial biofilms, and for the natural whitening of tooth enamel30 Jul 2026US 2026/0216042 A1
- Processes of producing fermentation products30 Apr 2026US 2026/0117266 A1Novozymes North America, Inc.
Most cited
By later US patents
- Oral immunization by transgenic plants68US 5,654,184 AWashington University · 1997
- Oral immunization by transgenic plants60US 5,679,880 AWashington University · 1997
- Oral immunization by transgenic plants56US 5,686,079 AWashington University · 1997
- Xylanase derived from a Bacillus species, expression vectors for such xylanase and other proteins, host organisms therefor and use thereof50US 6,426,211 B1Genencor International, Inc. · 2002
- Self-processing plants and plant parts43US 7,102,057 B2Syngenta Participations AG · 2006